Company Filing History:
Years Active: 2007
Title: Herbert Jünger: Innovator in Pharmaceutical Development
Introduction
Herbert Jünger is a notable inventor based in Dachau, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable drug formulations. His work has implications for improving the efficacy and reliability of oral medications.
Latest Patents
Herbert Jünger holds a patent for a stable drug form for oral administration that utilizes benzimidazole derivatives as the active ingredient. The invention relates to a stable medicament designed for oral use, which enhances the stability and effectiveness of the drug. Additionally, the patent includes a method for the production of this stable medicament, showcasing Jünger’s innovative approach to pharmaceutical formulation.
Career Highlights
Jünger is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca has allowed him to contribute to the advancement of drug development and improve patient outcomes through innovative solutions.
Collaborations
Throughout his career, Herbert Jünger has collaborated with esteemed colleagues, including Gerd-Ulfert Heese and Arnim Laicher. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical research.
Conclusion
Herbert Jünger’s contributions to the pharmaceutical industry, particularly through his patent for a stable drug formulation, highlight his role as an innovator in the field. His work continues to influence the development of effective oral medications, benefiting patients worldwide.